Similar Items: Pharmacokinetics and safety of first -- and second--line anti-- tuberculosis drugs in children
- Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery
- Dynamics of interaction between MA and cholesterol in tuberculosis
- Development of a drug discovery protocol through the expression of key mycothiol biosynthetic enzymes for Mycobacterium tuberculosis
- Accuracy and impact of the MTBDRplus v2 and MTBDRsl v2 line probe assays for the detection of first-line and second-line drug resistant tuberculosis
- An analysis of the upstream supply chain for second-line drugs for multidrug-resistant tuberculosis
- Evaluation of a radiometrically-determined regrowth model for the study of anti-tuberculosis drugs
Author: Schaaf, Hendrik Simon
- Pharmacokinetics and safety of first -- and second--line anti-- tuberculosis drugs in children
- The epidemiology and management of drug-resistant tuberculosis in childhood
- Severity of pulmonary disease in infants less than three months with culture confirmed tuberculosis
- Hepatocellular injury in children treated for rifampicin-resistant tuberculosis: incidence, aetiology and outcome